Figures
Patient evaluation, Visceral leishmaniasis
Visceral leishmaniasis (VL) remains a major public health challenge in East Africa, particularly in Ethiopia. Clinical trials on VL often exclude patients with severe comorbidities or laboratory abnormalities, limiting the generalizability of evidence used to guide real-world management. This study comprehensively characterised the clinical profile, treatment outcomes, and mortality of VL patients treated in a referral centre. Ayele et al. 2026
Image Credit: Eleni Ayele
Citation: (2026) PLoS Neglected Tropical Diseases Issue Image | Vol. 20(6) July 2026. PLoS Negl Trop Dis 20(6): ev20.i06. https://doi.org/10.1371/image.pntd.v20.i06
Published: July 27, 2026
Copyright: © 2026 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visceral leishmaniasis (VL) remains a major public health challenge in East Africa, particularly in Ethiopia. Clinical trials on VL often exclude patients with severe comorbidities or laboratory abnormalities, limiting the generalizability of evidence used to guide real-world management. This study comprehensively characterised the clinical profile, treatment outcomes, and mortality of VL patients treated in a referral centre. Ayele et al. 2026
Image Credit: Eleni Ayele